David Vilchez
@thevilchezlab.bsky.social
2.4K followers 2.5K following 57 posts
Biologist, Professor at CECAD, University of Cologne. We study aging, age-related diseases, stem cell biology and proteostasis. http://www.davidvilchezlab.com/
Posts Media Videos Starter Packs
Reposted by David Vilchez
unicologne.bsky.social
🧓Wie das Altern neurodegenerative Krankheiten treibt 🧠

@thevilchezlab.bsky.social @cecad.bsky.social hat einen direkten molekularen Zusammenhang zwischen Altern und neurodegenerativen Krankheiten identifiziert.
Fluoreszenzfärbung von Neuronen unter einem Mikroskop mit grünen und blauen Markierungen auf dunklem Hintergrund.
Reposted by David Vilchez
unicologne.bsky.social
🧓How aging drives neurodegenerative diseases🧠
@thevilchezlab.bsky.social @cecad.bsky.social has identified a direct molecular link between aging and neurodegeneration by investigating how age-related changes in cell signalling contribute to toxic protein aggregation.
flourescent picture of motor neurons dyed green and blue (nucleus).
thevilchezlab.bsky.social
A titanic effort from Seda and the lab in collaboration with Nuria Flames’ lab ‪@sedakoyuncu.bsky.social‬ @unicologne.bsky.social@cecad.bsky.social‬ ‪@ibv-csic.bsky.social‬ ‪@nataging.nature.com‬‬‬‬‬‬
thevilchezlab.bsky.social
We also discovered that the deubiquitinase USP4 leads to EPS8 accumulation during aging.
Reducing USP4 prevented EPS8 accumulation, extended lifespan, and lessened disease effects.
👉 Targeting EPS8/USP4 could open new therapeutic strategies for neurodegeneration.
thevilchezlab.bsky.social
In C. elegans & human cells, we found that age-related EPS8/RAC signaling hyperactivation promotes pathological aggregation of fifferent proteins (polyQ, FUS, TDP-43).
Decreasing EPS8 (or tuning RAC signaling) prevents aggregation & and neurodegeneration.
thevilchezlab.bsky.social
I was just wondering the same thing, given the number of recent papers along these lines
thevilchezlab.bsky.social
Franziska Hommen did an excellent job in her thesis defense — we have a new PhD in the building! @cecad.bsky.social @cga-age.bsky.social
thevilchezlab.bsky.social
Learning a lot and having fun at the #OpenDay #Science @cecad.bsky.social @mpiage.bsky.social
thevilchezlab.bsky.social
The project will be carried out at the CECAD Research Center (University of Cologne): @unicologne.bsky.social @uniklinikkoeln.bsky.social @cecad.bsky.social
thevilchezlab.bsky.social
We have a 4-year postdoc position open in our Research Unit on proteostasis!
The project explores inter-tissue regulation using advanced proteomics approaches.
Collaborative & interdisciplinary environment. More details & application here:
jobs-uk-koeln.onlyfy.jobs/job/pktg6ivj...
Postdoc Position (f/m/x)
We are looking to support our rapidly growing team as soon as possible:
jobs-uk-koeln.onlyfy.jobs
thevilchezlab.bsky.social
🤪🤪🤪🤪🤪🤪🤪🤪🤪
Reposted by David Vilchez
ctmurphy1.bsky.social
🧪#Celegans - I am very excited to announce the publication of our latest finding in transgenerational epigenetic inheritance (TEI) of learned pathogen avoidance - • C. elegans transgenerational avoidance of P. fluorescens is mediated by the Pfs1 sRNA and vab-1 www.science.org/doi/10.1126/...
C. elegans transgenerational avoidance of P. fluorescens is mediated by the Pfs1 sRNA and vab-1
C. elegans’ TEI of learned pathogen avoidance is induced by a third bacterial small RNA, Pfs1, from P. fluorescens 15.
www.science.org
thevilchezlab.bsky.social
The study is part of the CRC1678 consortium;) @crc1678.bsky.social
Reposted by David Vilchez
cp-trendsbiochem.bsky.social
Online now - a tribute to the memory of Prof. Joan J. Guinovart from Jordi Duran and Matthew Gentry.

Prof. Guinovart was a renowned biochemist in the field of glycogen metabolism and known for his leadership in science.

(1/4)
thevilchezlab.bsky.social
New work from our lab;)
biorxiv-cellbio.bsky.social
C9orf72 ALS-causing mutations lead to nucleoporin Nup107 aggregation and subsequent pathological changes https://www.biorxiv.org/content/10.1101/2025.04.16.649118v1
thevilchezlab.bsky.social
Happy to have you aboard, Bjoern!